Organisation paid for research Program year 2025 Source: CMS Open Payments

Riveldi and Associates LLC

Neither a doctor nor a teaching hospital

Research payments

$2,236,563

917 payments

Through program year 2025, Riveldi and Associates LLC is reported as receiving $2,236,563 in research payments, across 917 payments.

By program year

2 rows
Year Kind Amount Payments
2025 Research $1,828,739 810
2024 Research $407,824 107

Breakdown

Who paid Research payments · program years 2024–2025
  1. ITI, Inc. $2,183,996 901 payments
  2. Pfizer Inc. $52,567 16 payments
Studies the money was for Research payments · program years 2024–2025
  1. Iti-007-321 $1,237,121 550 payments
  2. Iti-007-421 $602,034 156 payments
  3. Iti-007-602 $344,841 195 payments
  4. A Phase 2 Randomized Doubleblind Trial to Evaluate the Safety Tolerability and Immunogenicity of A Multivalent Pneumococcal Conjugate Vaccine in Healthy Infants $52,567 16 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record